Request Demo
Last update 23 Jan 2025
VGKCs x Potassium channel x MGAM
Last update 23 Jan 2025
Basic Info
Related Targets |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
JPRN-UMIN000012294
Clinical study on of combination therapy with a DPP-4 inhibitor and a mitiglinide/voglibose fixed-dose combination (the combination) on glycemic/metabolic responses after meals in patients with type 2 diabetic mellitus (T2DM) - Clinical study on combination therapy with a DPP-4 inhibitor and the combination in T2DM patients
JPRN-UMIN000011167
Efficacy and safety of switching from thrice daily glinide or alpha-GI to twice daily mitiglinide/voglibose combined drug in type 2 diabetes. - Efficacy and safety of switching from thrice daily glinide or alpha-GI to twice daily mitiglinide/voglibose combined drug in type 2 diabetes.
JPRN-UMIN000008332
Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial function - EGEF trial
100 Clinical Results associated with VGKCs x Potassium channel x MGAM
Login to view more data
100 Translational Medicine associated with VGKCs x Potassium channel x MGAM
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free